{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000162","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.926815+00:00","generated_at":"2026-05-16T20:24:21.115429+00:00","sec_items":["1.01","2.01","3.02","3.03","5.03","5.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"confidence":"high","headline":"Salarius completes acquisition of Decoy Therapeutics, raises ~$6.3M in public offering","bullets":["Closed merger with Decoy Therapeutics on Nov 12; issued Series A/B Preferred Stock convertible at 2,800:1 ratio post-anti-dilution adjustment.","Public offering priced at $1.50/unit (common + Series A/B warrants); net proceeds ~$6.3M, closed Nov 12.","Frederick Pierce (Decoy CEO) appointed CEO, replacing Mark Rosenblum who remains CFO; Dr. Barbara Hibner as CSO, Peter Marschel as CBO.","Board change: Pierce appointed Class II director; Bruce McCreedy resigned, not due to any disagreement.","Warrants: Series A (5-yr term, $1.50 exercise), Series B (1-yr term, $1.50), Pre-funded ($0.0001). Representative warrants also issued."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000162","json":"https://secwatch.observer/filing/0001615219-25-000162.json","markdown":"https://secwatch.observer/filing/0001615219-25-000162.md","text":"https://secwatch.observer/filing/0001615219-25-000162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000162/0001615219-25-000162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000162/flks-20251111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:24:21.115429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}